Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2005

View Archived Issues

Medivir reflects on Q3 developments

Targeting mGluR1 for epilepsy

USP7: new target for cancer with inhibitors identified at Hybrigenics

Bioreductive prodrugs facilitate selective targeting of hypoxic tumor regions

Novel tumor-localizing agents described

R-112 disappoints in phase II comparative study in allergic rhinitis

Bausch & Lomb and PTC Therapeutics collaborate in ophthalmology

ArQule seeks to begin phase I studies with ARQ-197

Wyeth awarded new contract for development of therapeutic HIV vaccines

Alza modifies U.S. clinical development program for OROS Hydromorphone

Second approvable letter for diquafosol tetrasodium ophthalmic solution

New phase I study investigates INNO-105 in advanced solid malignancies

Private equity financing to support NeurogesX' development of Transacin

Bausch & Lomb licenses compounds from Cephalon for ophthalmic use

Provectus studies PV-10 for breast cancer in phase I trial

ACP-103 reduces haloperidol-induced akathisia in patients with schizophrenia

Phase I data on chemotherapeutic RH1 presented

S-18407, a novel alpha4beta1 integrin inhibitor, effective in murine Lyme arthritis

Opticin found to induce antiangiogenic effects in vitro and in vivo

New cancer vaccine activates host immune response

New agents described for treating cardiovascular disorders

Novel compounds with potential for inflammatory disorders imparted in patents

Recent patents report new treatments for thrombotic disorders

Preclinical studies reveal activity of BMS-354825 in various cancer types

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...